OTCMKTS:CPMD CannaPharmaRX (CPMD) Stock Price, News & Analysis $0.0065 +0.00 (+8.33%) As of 02/19/2025 03:40 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest About CannaPharmaRX Stock (OTCMKTS:CPMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CannaPharmaRX alerts:Sign Up Key Stats Today's Range$0.0026▼$0.006550-Day Range$0.0051▼$0.009052-Week Range$0.00▼$0.03Volume590,000 shsAverage Volume108,667 shsMarket Capitalization$4.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.Read More… Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPMD Stock News HeadlinesCannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comPSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?February 20, 2025 | Colonial Metals (Ad)CannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deCannaPharmaRx, Inc.: CannaPharmaRx Completes First HarvestsMarch 12, 2024 | finanznachrichten.deSee More Headlines CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed this year? CannaPharmaRX's stock was trading at $0.0081 at the beginning of 2025. Since then, CPMD shares have decreased by 19.8% and is now trading at $0.0065. View the best growth stocks for 2025 here. How do I buy shares of CannaPharmaRX? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CannaPharmaRX own? Based on aggregate information from My MarketBeat watchlists, some other companies that CannaPharmaRX investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI). Company Calendar Today2/20/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CPMD CUSIPN/A CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.69 million Net MarginsN/A Pretax Margin408.11% Return on EquityN/A Return on Assets-41.99% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-0.22Miscellaneous Outstanding Shares660,630,000Free Float652,236,000Market Cap$4.29 million OptionableNot Optionable Beta2.34 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:CPMD) was last updated on 2/20/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.